Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT00822822
First received: January 13, 2009
Last updated: November 21, 2013
Last verified: October 2010
  Purpose

The purpose of this research study is to find out what Moffitt and Lifetime patients think of the electronic medical records process.


Condition Intervention
Cancer
Cancer Screening Patients
Patient Volunteers
Behavioral: First Questionnaire
Behavioral: Health History
Behavioral: Second Questionnaire

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assessment

Resource links provided by NLM:


Further study details as provided by H. Lee Moffitt Cancer Center and Research Institute:

Primary Outcome Measures:
  • Create a system for collecting patient health histories that may be beneficial to patients and people receiving services at Moffitt Cancer Center or Lifetime Cancer Screening Center [ Time Frame: 1 hour per participant ] [ Designated as safety issue: No ]

Enrollment: 17
Study Start Date: March 2006
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
A
Health History Process
Behavioral: First Questionnaire
Complete questionnaire before completing health history
Behavioral: Health History
Complete electronic health history
Behavioral: Second Questionnaire
Complete questionnaire after completing electronic health history

Detailed Description:

Patient will complete a questionnaire about their knowledge of computers and how long they think it will take them to finish the patient health history using a computer.

Patient will complete the electronic record carefully and tell us if they had any difficulties, questions or comments about the format.

Patient will answer a questionnaire about how well they liked or did not like using the electronic system to give their health history.

Participation in this study will take approximately 30 minutes to 1 hour.

  Eligibility

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

People receiving services at Moffitt Cancer Center or Lifetime Cancer Screening Center

Criteria

Inclusion Criteria:

  • The breakdown of patients recruited by stratified dimensional sampling. Overall, we will attempt to equally recruit patients from the unique strata for each domain evaluation in this study. Patients health status will be determined by the ECOG Performance status . We assume that all patients being seen at the Lifetime Cancer Screening and Prevention center will be of good to fair health, while patients seen at the Cancer hospital will range from good- to- fair to poor health status. Gender is also used as a sampling factor because there are modules within this web-based health history forms that are specific for each gender.

Exclusion Criteria:

  • Respondents who refuse to participate or who become too ill at any point in the assessment, will be excluded. Non-English speaking patients will be excluded. Names and other identifying information will not be collected and all data will be reported in aggregate form. Due to the nature of our stratified samples strategy, some patients will be excluded if they meet the criteria for a recruitment stata, but that stata is full.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00822822

Locations
United States, Florida
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States, 33612
Sponsors and Collaborators
H. Lee Moffitt Cancer Center and Research Institute
Investigators
Principal Investigator: Erin Siegel, Ph.D. H. Lee Moffitt Cancer Center and Research Institute
  More Information

Additional Information:
No publications provided

Responsible Party: H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier: NCT00822822     History of Changes
Other Study ID Numbers: MCC-14731, 104330
Study First Received: January 13, 2009
Last Updated: November 21, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by H. Lee Moffitt Cancer Center and Research Institute:
Questionnaire
Electronic Health History

ClinicalTrials.gov processed this record on July 24, 2014